Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers

Journal of Hepatology

Volumn 49, Issue 4, 2008, Pages 581-588

  Schwartz, Myron ^a   Dvorchik, Igor ^c   Roayaie, Sasan ^a   Isabel Fiel, M ^a   Finkelstein, Sidney ^c   Wallis Marsh, J ^c   Martignetti, John A ^b   Llovet, Josep M ^a,d  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Allelic imbalance; Biomarkers; Hepatocellular carcinoma; Liver transplantation extended indications

Indexed keywords

MICROSATELLITE DNA; MOLECULAR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ALGORITHMS; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 50549094380     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.03.032     Document Type: Article

References (30)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
3. Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 127 (2004) S268-S276
4. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181-200
5. Roayaie S., Frischer J.S., Emre S.H., Fishbein T.M., Sheiner P.A., Sung M., et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235 (2002) 533-539
6. Yao F.Y., Ferrell L., Bass N.M., Bacchetti P., Ascher N.L., and Roberts J.P. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the milan criteria and the pittsburgh modified TNM criteria. Liver Transpl 8 (2002) 765-774
7. Llovet J.M., and Wurmbach E. Gene expression profiles in hepatocellular carcinoma: not yet there. J Hepatol 41 (2004) 336-339
8. Lee J.S., Chu I.S., Heo J., Calvisi D.F., Sun Z., Roskams T., et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 40 (2004) 667-676
9. Iizuka N., Hamamoto Y., and Oka M. Predicting individual outcomes in hepatocellular carcinoma. Lancet 364 (2004) 1837-1839
10. Kurokawa Y., Matoba R., Takemasa I., Nagano H., Dono K., Nakamori S., et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 41 (2004) 284-291
11. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
12. Marsh J.W., Finkelstein S.D., Demetris A.J., Swalsky P.A., Sasatomi E., Bandos A., et al. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival. Liver Transpl 9 (2003) 664-671
13. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
14. Finkelstein S.D., Marsh W., Demetris A.J., Swalsky P.A., Sasatomi E., Bonham A., et al. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology 37 (2003) 871-879
15. Kirimlioglu H., Dvorchick I., Ruppert K., Finkelstein S., Marsh J.W., Iwatsuki S., et al. Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications. Hepatology 34 (2001) 502-510
16. Dacic S., Ionescu D.N., Finkelstein S., and Yousem S.A. Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol 29 (2005) 897-902
17. Krishnamurti U., Sasatomi E., Swalsky P.A., Jones M.W., and Finkelstein S.D. Microdissection-based mutational genotyping of serous borderline tumors of the ovary. Int J Gynecol Pathol 24 (2005) 56-61
18. Rao U.N., Goodman M., Chung W.W., Swalski P., Pal R., and Finkelstein S. Molecular analysis of primary and recurrent giant cell tumors of bone. Cancer Genet Cytogenet 158 (2005) 126-136
19. Beckner M.E., Sasatomi E., Swalsky P.A., Hamilton R.L., Pollack I.F., and Finkelstein S.D. Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13. Hum Pathol 35 (2004) 1105-1111
20. Hunt J.L., Fowler M., Lomago D., Niehouse L., Sasatomi E., Swalsky P., et al. Tumor suppressor gene allelic loss profiles of the variants of papillary thyroid carcinoma. Diagn Mol Pathol 13 (2004) 41-46
21. Khalid A., Pal R., Sasatomi E., Swalsky P., Slivka A., Whitcomb D., et al. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 53 (2004) 1860-1865
22. Lee J.Y., Finkelstein S., Hamilton R.L., Rekha R., King Jr. J.T., and Omalu B. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas. Neurosurgery 55 (2004) 1163-1173
23. Ariyanayagam-Baksh S.M., Baksh F.K., Swalsky P.A., and Finkelstein S.D. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma. Mod Pathol 16 (2003) 992-995
24. Dacic S., Finkelstein S.D., Baksh F.K., Swalsky P.A., Barnes L.E., and Yousem S.A. Small-cell neuroendocrine carcinoma displays unique profiles of tumor-suppressor gene loss in relationship to the primary site of formation. Hum Pathol 33 (2002) 927-932
25. Raja S., Finkelstein S.D., Baksh F.K., Gooding W.E., Swalsky P.A., Godfrey T.E., et al. Correlation between dysplasia and mutations of six tumor suppressor genes in barrett's esophagus. Ann Thorac Surg 72 (2001) 1130-1135
26. Iacobuzio-Donahue C.A., van der Heijden M.S., Baumgartner M.R., Troup W.J., Romm J.M., Doheny K., et al. Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss. Cancer Res 64 (2004) 871-875
27. Pawlik T.M., Gleisner A.L., Anders R.A., Assumpcao L., Maley W., and Choti M.A. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 245 (2007) 435-442
28. Cillo U., Vitale A., Bassanello M., Boccagni P., Brolese A., Zanus G., et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 239 (2004) 150-159
29. Burrel M., Llovet J.M., Ayuso C., Iglesias C., Sala M., Miquel R., et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 38 (2003) 1034-1042
30. Ravaioli M., Ercolani G., Cescon M., Vetrone G., Voci C., Grigioni W.F., et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 10 (2004) 1195-1202